The world’s first fully automated random access biochip testing platform, the Evidence Evolution is set to revolutionise current diagnostic testing. With the capability to process up to 2,640 tests per hour, the Evidence Evolution offers complete system integration, as well as the most comprehensive test menu on the market.
Using the same multiplexing technology as the fully automated Evidence and the semi-automated Evidence Investigator, the Evidence Evolution is a transformational platform, providing advanced test consolidation and patient profiling.
The Evidence Evolution offers true on-board random access, state of the art intuitive e-touch software and advanced precision bio-drive robotics.
Features & Benefits
- Up to 2,640 test results per hour
- Rapid multiplex testing from a single sample
- Fully automated
- Time and cost savings
- High quality, reliable results
- Extensive range of arrays, with more in development
|Cardiac array||Fertility hormone array||Thyroid Free array||Tumor PSA array|
|Adhesion molecules array||Cerebral array I||Cerebral array II||Cytokine array I|
|Cytokine array II||Cytokine array III||Cytokine array IV||Endocrine array|
|Metabolic syndrome I||Metabolic syndrome II|
|Drugs of Abuse array I Plus||Drugs of Abuse array II||Drugs of Abuse array III||Drugs of Abuse array IV|
|Drugs of Abuse array V||Duid array|